Barclays Plc - Aug 8, 2022 Form 3 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
10%+ Owner
Signature
Suejean Mott
Stock symbol
NERV
Transactions as of
Aug 8, 2022
Transactions value $
$0
Form type
3
Date filed
8/10/2022, 02:07 PM
Previous filing
Jul 19, 2022
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NERV Common Stock, $0.0001 par value per share 408K Aug 8, 2022 By Barclays Bank PLC
holding NERV Common Stock, $0.0001 par value per share 197K Aug 8, 2022 By Barclays Capital Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(a) Beneficially owned ordinary shares are comprised in Units, each consisting of one ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital, Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if non, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital, Inc. 745 7th Avenue New York, New York 10019 United States